← Open Payments lookup

JARED BRABHAM: Open Payments

NPI 1134763576 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$899 in 61 payments from 10 companies in 2025. Trend: 2023 $208 · 2024 $484 · 2025 $899

Food & beverage: $899
CompanyPaymentsAmount
ABBVIE INC.16$190
Vanda Pharmaceuticals Inc.15$171
Teva Pharmaceuticals USA, Inc.8$142
E.R. Squibb & Sons, L.L.C.10$139
Janssen Pharmaceuticals, Inc3$78
Neurocrine BioSciences, Inc.2$42
Otsuka America Pharmaceutical, Inc.2$41
Indivior Inc.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Alkermes, Inc.1$26

Products named: VRAYLAR, FANAPT, COBENFY, UZEDY, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, SUBLOCADE.

Industry payments across LA — which companies pay providers there.